JP Morgan Chase’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,035,288
Closed -$51.8M 7865
2025
Q4
$51.8M Sell
1,035,288
-184,562
-15% -$8.87M ﹤0.01% 1347
2025
Q3
$59.9M Buy
1,219,850
+878,149
+257% +$45M ﹤0.01% 1294
2025
Q2
$17.7M Sell
341,701
-4,061
-1% -$187K ﹤0.01% 2043
2025
Q1
$16.2M Sell
345,762
-89,781
-21% -$4.63M ﹤0.01% 2092
2024
Q4
$22.3M Buy
435,543
+72,745
+20% +$3.77M ﹤0.01% 1938
2024
Q3
$16.1M Sell
362,798
-28,234
-7% -$1.23M ﹤0.01% 2175
2024
Q2
$15.7M Buy
391,032
+23,107
+6% +$876K ﹤0.01% 2054
2024
Q1
$14.7M Buy
367,925
+3,487
+1% +$131K ﹤0.01% 2149
2023
Q4
$13.7M Sell
364,438
-79,714
-18% -$2.44M ﹤0.01% 2168
2023
Q3
$12.3M Buy
444,152
+40,379
+10% +$1.26M ﹤0.01% 2071
2023
Q2
$12.2M Sell
403,773
-77,509
-16% -$2.27M ﹤0.01% 2117
2023
Q1
$14.8M Buy
481,282
+89,426
+23% +$3.41M ﹤0.01% 1912
2022
Q4
$14.7M Buy
391,856
+1,197
+0.3% +$47.5K ﹤0.01% 1908
2022
Q3
$14.7M Sell
390,659
-68,018
-15% -$2.7M ﹤0.01% 1832
2022
Q2
$16.5M Buy
458,677
+20,498
+5% +$848K ﹤0.01% 1760
2022
Q1
$21.5M Sell
438,179
-41,805
-9% -$2.12M ﹤0.01% 1715
2021
Q4
$23M Sell
479,984
-12,719
-3% -$602K ﹤0.01% 1707
2021
Q3
$21.6M Buy
492,703
+42,392
+9% +$1.79M ﹤0.01% 1698
2021
Q2
$19.8M Sell
450,311
-10,477
-2% -$492K ﹤0.01% 1858
2021
Q1
$21.1M Buy
460,788
+41,451
+10% +$1.74M ﹤0.01% 1726
2020
Q4
$13.6M Buy
419,337
+77,594
+23% +$2.24M ﹤0.01% 1949
2020
Q3
$7.09M Buy
341,743
+2,059
+0.6% +$42.9K ﹤0.01% 2298
2020
Q2
$6.97M Buy
339,684
+175,263
+107% +$3.39M ﹤0.01% 2196
2020
Q1
$2.89M Sell
164,421
-230,536
-58% -$7.1M ﹤0.01% 2698
2019
Q4
$15.5M Sell
394,957
-656,908
-62% -$24.1M ﹤0.01% 1766
2019
Q3
$37.6M Sell
1,051,865
-91,142
-8% -$3.27M 0.01% 1108
2019
Q2
$39M Sell
1,143,007
-278,001
-20% -$9.66M 0.01% 1103
2019
Q1
$48.8M Sell
1,421,008
-96,930
-6% -$3.56M 0.01% 964
2018
Q4
$48.6M Buy
1,517,938
+199,686
+15% +$7.53M 0.01% 911
2018
Q3
$60.4M Buy
1,318,252
+852,158
+183% +$42.9M 0.01% 925
2018
Q2
$24.6M Sell
466,094
-517,776
-53% -$27.5M 0.01% 1432
2018
Q1
$49.1M Sell
983,870
-453,464
-32% -$22.8M 0.01% 947
2017
Q4
$68.9M Buy
1,437,334
+209,278
+17% +$9.91M 0.01% 819
2017
Q3
$56M Buy
1,228,056
+35,637
+3% +$1.54M 0.01% 869
2017
Q2
$52.8M Sell
1,192,419
-44,596
-4% -$1.87M 0.01% 881
2017
Q1
$50.7M Buy
1,237,015
+387,782
+46% +$16.2M 0.01% 941
2016
Q4
$34.9M Buy
849,233
+425,273
+100% +$15.6M 0.01% 1109
2016
Q3
$13.8M Sell
423,960
-311,557
-42% -$9.78M ﹤0.01% 1580
2016
Q2
$21.3M Buy
735,517
+93,420
+15% +$2.84M 0.01% 1354
2016
Q1
$18.6M Buy
642,097
+270,505
+73% +$7.75M ﹤0.01% 1384
2015
Q4
$12M Buy
371,592
+17,228
+5% +$549K ﹤0.01% 1692
2015
Q3
$10.5M Buy
354,364
+77,528
+28% +$2.38M ﹤0.01% 1721
2015
Q2
$8.53M Buy
276,836
+110,127
+66% +$3.18M ﹤0.01% 2035
2015
Q1
$4.67M Buy
166,709
+53,559
+47% +$1.45M ﹤0.01% 2402
2014
Q4
$3.06M Sell
113,150
-5,450
-5% -$138K ﹤0.01% 2717
2014
Q3
$2.8M Sell
118,600
-32,150
-21% -$771K ﹤0.01% 2714
2014
Q2
$3.67M Sell
150,750
-112,509
-43% -$2.62M ﹤0.01% 2230
2014
Q1
$6.25M Buy
263,259
+23,174
+10% +$563K ﹤0.01% 1959
2013
Q4
$6.05M Sell
240,085
-38,428
-14% -$906K ﹤0.01% 2049
2013
Q3
$6.43M Buy
278,513
+162,780
+141% +$3.71M ﹤0.01% 2038
2013
Q2
$2.37M Buy
+115,733
New +$2.19M ﹤0.01% 2687

Other funds holding SNV

JP Morgan Chase's SNV Position: Q1 2026 in Review

JP Morgan Chase sold out of Synovus (SNV) in Q1 2026, closing a stake of 1,035,288 shares — an estimated $51.8M sold.

JP Morgan Chase first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $68.9M in Q4 2017. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • JP Morgan Chase reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 1,035,288 Synovus shares in Q1 2026, an estimated $51.8M.
  • JP Morgan Chase first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • JP Morgan Chase's Synovus position peaked at $68.9M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.